The combination of one dose of the cytostatic agent (bromoanalog of ifosfamide) administration with subsequent peritumoral injections of the cytokine-producing cells was observed to be more efficient in the tumor growth inhibition as compared with the cytostatic alone.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.